Waklert 150 mg contains armodafinil, a prescription wakefulness-promoting agent used to treat excessive daytime sleepiness associated with narcolepsy, obstructive sleep apnea, and shift work sleep disorder. Armodafinil is the R-enantiomer of modafinil and helps support wakefulness by acting on neurotransmitter pathways involved in the sleep–wake cycle.
In Australia, armodafinil is regulated as a Schedule 4 (prescription-only) medicine under Therapeutic Goods Administration (TGA) guidelines. This means Waklert 150 mg can only be legally supplied with a valid prescription from a registered Australian medical practitioner and dispensed through a licensed pharmacy.
Patients interested in Waklert 150 in Australia should undergo proper medical assessment to determine clinical need, rule out contraindications (such as cardiovascular or psychiatric issues), and ensure safe, compliant use. Importing prescription medications without authorization may violate Australian therapeutic goods laws.
Read more:
Waklert 150 Australia
Locked
